期刊文献+

盐酸左氧氟沙星体内外抗菌作用研究 被引量:19

In Vitro and in Vivo Antibacterial Activities of Levofloxacin against Clinic Isolates
下载PDF
导出
摘要 目的评价盐酸左氧氟沙星对临床常见致病菌的体内外抗菌活性。方法采用试管二倍稀释法测定最低抑菌浓度(MIC),并对其影响因素进行测定,同时与对照药左氧氟沙星、氧氟沙星进行对比。结果盐酸左氧氟沙星对金黄色葡萄球菌(金葡菌)、表皮葡萄球菌、肺炎球菌等革兰阳性菌有较强的抗菌活性,MIC50为0.16~0.62μg.mL-1;对肠杆菌科细菌如变形杆菌、大肠埃希菌、肺炎克雷白杆菌等革兰阴性菌也有较强的抗菌活性,MIC50为0.31~1.25μg.mL-1;盐酸左氧氟沙星在酸性条件下抗菌活性降低,随着血清浓度及细菌接种量的提高,盐酸左氧氟沙星的MIC值增大2~4倍;盐酸左氧氟沙星对金葡菌、大肠埃希菌感染小鼠有明显的保护作用,其ED50分别为4.54,1.21 mg.kg-1,盐酸左氧氟沙星的作用与左氧氟沙星相似,但明显强于氧氟沙星。结论盐酸左氧氟沙星对临床常见致病菌有良好的抗菌作用。 Objective To evaluate in vitro and in clinical isolates and compare with levofloxacin and ofloxacin . vivo antibacterial activities of levofloxacin hydrochloride against Methods Minimal inhibitory concentration (MIC) tests were carried out using the broth-dilutions methods . The affecting factors were also determined. Drugs were administered intravenously 1 h after mice were infected intraperitoneally with 1 mL of bacterial suspension . The median effective dose ( ED50 ) was calculated by the probit method. Results Levofloxacin hydrochloride had strong activity against gram-positive bacteria , such as staphylococcus aureus , staphylococcus epidermidis and streptococcus pneumoniae with MIC50s 0. 16-0.62μg·mL^-1. It was also active against gram-negative bacteria , such as escherichia coli , proteus and klebsiella pneumoniae with MIC50 s 0. 31- 1.25μg·mL^-1. The antibacterial activity of levofloxacin hydrochloride decreased under acidic condition , increase of serum concentration and bacteria inoculum size . The protective effects of levofloxacin hydrochloride against experimental systemic infections were observed. ED50s of levofloxacin hydrochloride against staphylococcus aureus and escherichia coli were 4.54 and 1. 21 mg · kg^-1 , respectively . Levofloxacin hydrochloride was as active as levofloxacin and was more active than ofloxacin . Conclusion Levofloxacin hydrochloride shows a good activity against clinical isolates , its in vitro antibacterial activities can be changed by pH , serum concentration in culture media and inoculum size .
出处 《医药导报》 CAS 2007年第9期983-986,共4页 Herald of Medicine
关键词 左氧氟沙星 盐酸 抗菌活性 体内 体外 Levofloxoein hydrochloride Antibacterial activities In vitro In vivo
  • 相关文献

参考文献8

二级参考文献35

  • 1祝承霞.新喹诺酮Levofeoxacin的药理和临床评价[J].国外医药(抗生素分册),1993,14(4):294-299. 被引量:19
  • 2肖永红.斯巴沙星[J].重庆医科大学学报,1995,20(4):336-338. 被引量:3
  • 3汪复,张敬德,朱德妹,王宇倩,周乐,张婴元.Du6859a及其他新的氟喹诺酮类药物的体外抗菌活性[J].中国抗生素杂志,1996,21(3):214-219. 被引量:13
  • 4File TM Jr,Segreti J,Dunbar L,et al.A multicenter,randomized study comparing the safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in the treatment of adults with community-acquired pneumonia[J].Antimicrob Agents Chemoth,1997,41:1965-1972.
  • 5Marrie TJ.Experience with levofloxacin in critical pathway for the treatment of community-acquired pneumonia[J].Chemotherapy,2004,50 (Suppl 1):11-15.
  • 6Frank E,Liu J,Kinasewitz G,Moran GJ,et al.A multicenter open-label,randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia[J].Clin Ther,2002,24:1292-1308.
  • 7Mandell LA,Bartlett JG,Dowell SF,et al.Infectious Diseases Society of America.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults[J].Clin Infect Dis,2003,37:1405-1433.
  • 8Bartlett JG,Dowell SF,Mandell LA,et al.Practice guidelines for the management of community-acquired pneumonia in adults.Infectious Diseases Society of America[J].Clin Infect Dis,2000,31:347-382.
  • 9Ball P.Efficacy and safety of levofloxacin in the context of other contemporary fluroquinolones:A review.Current Therapeutic Research[J].2003,64:646-661.
  • 10Hurst M,Lamb HM,Scott L J,et al.Levofloxacin:An updated review of its use in the treatment of bacterial infections[J].Drugs,2002,62:2127-2167.

共引文献17

同被引文献133

引证文献19

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部